Blue Line Protection Group Provides Financial Review
Denver, CO, April 24, 2024 (GLOBE NEWSWIRE) -- Blue Line Protection Group Inc. (OTCQB: BLPG) is pleased to summarize the 2023 financial results. 2023 was a profitable year for the Company, as shown in our 10K filing. Revenue grew by 13% respectively, and operating income rose to an impressive $762,713. Total assets grew by $478,493 and shareholders deficit was reduced by $518,470. Additionally, the Company processed over $1,400,000,000 in cash pickups throughout 2023, with that number anticipated to increase in 2024.
As our presence and reputation has become more established in the State of New Mexico, our clientele has continued to grow, with new banks and clients being onboarded weekly. Compared to the prior year, 2023 saw over a 1000% growth in revenue in this market.
Our Arizona branch continues to produce strong revenue numbers, as the medical and recreational shops in the industry post impressive sales numbers. Being an industry leader in the State of Arizona, the Company transports over 70% of all the legal cannabis sales for deposit verification and transportation to the Federal Reserve Bank.
Colorado and Nevada continue to produce as mature markets, and have seen the industry consolidate. The Company continues to lead with a superior service and safety reputation, and therefore continues to grow, onboarding clients monthly.
For questions or more information contact:
Dan Allen
Blue Line Protection Group, Inc.
(800)844-5576
-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits